A carregar...
Xanomeline and the Antipsychotic Potential of Muscarinic Receptor Subtype Selective Agonists
Binding studies initially suggested that the muscarinic agonist, xanomeline, was a subtype selective muscarinic M (1) receptor agonist, and a potential new treatment for Alzheimer's disease. However, later in vitro and in vivo functional studies suggest that this compound is probably better des...
Na minha lista:
| Publicado no: | CNS Drug Rev |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Ltd
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741650/ https://ncbi.nlm.nih.gov/pubmed/12847557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2003.tb00247.x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|